{
  "meta": {
    "title": "00015_Mid_Day_Module_Medicine-4",
    "url": "https://brainandscalpel.vercel.app/00015-mid-day-module-medicine-4-d4d143e4.html",
    "scrapedAt": "2025-11-29T18:11:49.893Z"
  },
  "questions": [
    {
      "id": 6613,
      "choices": [
        {
          "id": 26421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Digoxin </span></span></span></p>"
        },
        {
          "id": 26422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart transplantation </span></span></span></p>"
        },
        {
          "id": 26423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left ventricular assist device (LVAD) placement </span></span></span></p>"
        },
        {
          "id": 26424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tolvaptan</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man with ischemic cardiomyopathy (EF 20%) is on maximally tolerated heart failure medications and experiencing significant functional decline. He wishes to pursue care that will restore functionality. What is the most appropriate long-term treatment?</span></span></p>",
      "unique_key": "Q9379264",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974417,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Heart transplantation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heart transplantation is the most appropriate long-term treatment for patients with advanced heart failure who have persistent severe symptoms despite optimal medical therapy. It can significantly improve quality of life and survival in suitable candidates. This patient&#39;s young age (56 years old) and desire for functional improvement make him a potential candidate for transplantation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Digoxin:</span></strong><span style=\"font-size:12.0pt\"> Although it can reduce hospitalizations, it does not improve survival or functional capacity. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. LVAD placement:</span></strong><span style=\"font-size:12.0pt\"> LVADs are a bridge to transplantation or destination therapy for those who are not transplant candidates. This patient may be eligible for transplant. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tolvaptan:</span></strong><span style=\"font-size:12.0pt\"> Used for hyponatremia, but not a primary treatment for advanced heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with persistent severe heart failure symptoms despite maximal medical therapy are candidates for advanced treatment; acceptable candidates for cardiac transplantation are generally younger than 65 to 70 years with no medical contraindications and have good social support and adherence.</span></span></p>",
      "correct_choice_id": 26422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6614,
      "choices": [
        {
          "id": 26425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Add eplerenone</span></span></span></p>"
        },
        {
          "id": 26426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Add ivabradine </span></span></span></p>"
        },
        {
          "id": 26427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch carvedilol to metoprolol succinate </span></span></span></p>"
        },
        {
          "id": 26428,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch losartan to valsartan-sacubitril</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old man with a history of HFrEF and AF, presents for follow-up with stable NYHA class III symptoms. He is currently on losartan, carvedilol, empagliflozin, furosemide, and apixaban. He has a history of ACE inhibitor-induced angioedema and spironolactone-induced gynecomastia. Which medication is the most appropriate addition to his current regimen?</span></span></p>",
      "unique_key": "Q3070788",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974418,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Add eplerenone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eplerenone, a selective aldosterone antagonist, is indicated in patients with symptomatic HFrEF and normal kidney function to improve survival. This patient has normal renal function and has not tolerated spironolactone due to gynecomastia. Eplerenone is a suitable alternative as it has a lower risk of endocrine side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Ivabradine:</span></strong><span style=\"font-size:12.0pt\"> Not indicated in patients with atrial fibrillation. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Switch carvedilol to metoprolol succinate:</span></strong><span style=\"font-size:12.0pt\"> Not necessary, as there is no evidence of <strong>benefit in switching between beta-blockers in this scenario. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Switch losartan to valsartan-sacubitril:</span></strong><span style=\"font-size:12.0pt\"> Contraindicated due to the history of ACE inhibitor-induced angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aldosterone antagonist therapy (spironolactone, eplerenone) is indicated in all patients with symptomatic heart failure with reduced ejection fraction and normal kidney function to improve survival.</span></span></span></p>",
      "correct_choice_id": 26425,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6615,
      "choices": [
        {
          "id": 26429,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Addition of valsartan-sacubitril </span></span></span></p>"
        },
        {
          "id": 26430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Implantable cardioverter-defibrillator (ICD) therapy </span></span></span></p>"
        },
        {
          "id": 26431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Replacement of metoprolol with carvedilol </span></span></span></p>"
        },
        {
          "id": 26432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Septal reduction therapy (SRT)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old man with hypertrophic cardiomyopathy (HCM) diagnosed at age 38 presents with exertional dyspnea. He is on metoprolol and disopyramide. Echocardiogram shows asymmetric septal hypertrophy, systolic anterior motion of the mitral valve (SAM), and a resting LVOT gradient of 64 mmHg. What is the most appropriate treatment?</span></span></p>",
      "unique_key": "Q8465237",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974419,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Septal reduction therapy (SRT)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SRT is indicated for patients with symptomatic HCM and an LVOT gradient &ge;50 mmHg despite optimal medical therapy. This patient&#39;s symptoms and high LVOT gradient warrant consideration for SRT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Valsartan-sacubitril:</span></strong><span style=\"font-size:12.0pt\"> This medication is contraindicated in HCM due to the risk of worsening LVOT obstruction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. ICD therapy:</span></strong><span style=\"font-size:12.0pt\"> Indicated for primary prevention of sudden cardiac death in high-risk HCM patients but not the primary treatment for symptoms. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Replacement of metoprolol with carvedilol:</span></strong><span style=\"font-size:12.0pt\"> Unlikely to be beneficial as both are beta-blockers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Septal reduction therapy is indicated for symptomatic HCM patients with a significant LVOT gradient despite optimal medical therapy.</span></span></span></p>",
      "correct_choice_id": 26432,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6616,
      "choices": [
        {
          "id": 26433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ascending aortic dissection </span></span></span></p>"
        },
        {
          "id": 26434,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coronary artery dissection </span></span></span></p>"
        },
        {
          "id": 26435,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coronary artery embolism </span></span></span></p>"
        },
        {
          "id": 26436,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Takotsubo cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 76-year-old woman presents with acute substernal chest discomfort and dyspnea after seeing her dog being attacked and killed by another dog. Her echocardiogram shows apical and mid-ventricular hypokinesis with preserved basal function, and coronary angiography is normal. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q4638172",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974420,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Takotsubo cardiomyopathy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Takotsubo cardiomyopathy, also called stress-induced cardiomyopathy, mimics acute coronary syndrome (ACS) with chest pain, dyspnea, and elevated cardiac biomarkers. However, it occurs without obstructive coronary artery disease and typically presents with apical ballooning on echocardiography. Emotional stress is a common trigger.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. &nbsp;Ascending aortic dissection:</span></strong><span style=\"font-size:12.0pt\"> This would typically present with severe tearing chest pain radiating to the back. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Coronary artery dissection:</span></strong><span style=\"font-size:12.0pt\"> This would show abnormalities on angiography. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Coronary artery embolism:</span></strong><span style=\"font-size:12.0pt\"> This would also cause regional wall motion abnormalities on echocardiogram.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Takotsubo cardiomyopathy is a syndrome characterized by transient regional systolic ventricular dysfunction mimicking myocardial infarction in the absence of angiographic evidence of obstructive coronary artery disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of takotsubo cardiomyopathy is similar to that for heart failure of other causes; most patients recover cardiac function over several months.</span></span></p>",
      "correct_choice_id": 26436,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6618,
      "choices": [
        {
          "id": 26441,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bisoprolol</span></span></span></p>"
        },
        {
          "id": 26442,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diltiazem </span></span></span></p>"
        },
        {
          "id": 26443,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enalapril </span></span></span></p>"
        },
        {
          "id": 26444,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ivabradine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 27-year-old woman, 6 days postpartum, presents with acute heart failure symptoms (orthopnea, paroxysmal nocturnal dyspnea, elevated JVP, S3, crackles, edema). Echocardiogram shows an ejection fraction (EF) of 20% and diffuse hypokinesis. She is currently on furosemide and bilevel positive airway pressure (BiPAP). What is the most appropriate additional treatment?</span></span></span></p>",
      "unique_key": "Q2718510",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974421,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Enalapril</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient presents with peripartum cardiomyopathy (PPCM), a form of heart failure with reduced ejection fraction (HFrEF). ACE inhibitors like enalapril are the cornerstone of HFrEF treatment and have been shown to reduce morbidity and mortality. They can be safely used in breastfeeding women.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Bisoprolol (beta-blocker):</span></strong><span style=\"font-size:12.0pt\"> While beneficial in HFrEF, it should be initiated cautiously after volume status is optimized in acute decompensated heart failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Diltiazem (non-dihydropyridine calcium channel blocker):</span></strong><span style=\"font-size:12.0pt\"> Contraindicated in HFrEF due to negative inotropic effects. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Ivabradine:</span></strong><span style=\"font-size:12.0pt\"> Used in HFrEF patients with sinus rhythm and elevated heart rate despite optimal beta-blocker therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ACE inhibitors reduce morbidity and mortality in patients with heart failure with reduced ejection fraction and should be used in both symptomatic and asymptomatic patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol, carvedilol, and bisoprolol reduce mortality in patients with heart failure with reduced ejection fraction, but treatment should be delayed in patients with volume overload until the patient is closer to being euvolemic.</span></span></p>",
      "correct_choice_id": 26443,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6619,
      "choices": [
        {
          "id": 26445,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Athlete&#39;s heart </span></span></span></p>"
        },
        {
          "id": 26446,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fabry disease </span></span></span></p>"
        },
        {
          "id": 26447,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertensive heart disease </span></span></span></p>"
        },
        {
          "id": 26448,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nonobstructive hypertrophic cardiomyopathy (HCM)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old man with no prior medical history undergoes a pre-participation sports examination. ECG shows sinus bradycardia and voltage criteria for left ventricular (LV) hypertrophy. Echocardiogram shows mild LV dilation and symmetric LV hypertrophy with a normal LV ejection fraction and diastolic function. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8327083",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974422,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Athlete&#39;s heart</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Athlete&#39;s heart is a benign condition characterized by physiological cardiac remodeling in response to intense exercise. The ECG findings of sinus bradycardia and LV hypertrophy are common in athletes. Echocardiogram may also show mild LV dilation and increased wall thickness, but diastolic function remains normal, differentiating it from pathological conditions like HCM. Also, hypertrophy in the athlete&rsquo;s heart regresses with cessation of training and is accompanied by <em><u>supernormal exercise capacity</u></em> (VO2max &gt;50 mL/kg per min). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Fabry disease:</span></strong><span style=\"font-size:12.0pt\"> A lysosomal storage disorder that can cause LV hypertrophy but is also associated with other systemic manifestations like angiokeratomas and renal dysfunction. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Hypertensive heart disease:</span></strong><span style=\"font-size:12.0pt\"> Usually occurs in older individuals with a history of hypertension. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Nonobstructive HCM:</span></strong><span style=\"font-size:12.0pt\"> A genetic disorder that causes asymmetric LV hypertrophy and often has impaired diastolic function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased left ventricular (LV) wall thickness and LV cavity dilatation may be normal findings in highly trained athletes; symmetric wall thickness of 13 mm or less and normal diastolic filling favor the diagnosis of athlete heart over the diagnosis of HCM.</span></span></span></p>",
      "correct_choice_id": 26445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6620,
      "choices": [
        {
          "id": 26449,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac resynchronization therapy-defibrillator (CRT-D) </span></span></span></p>"
        },
        {
          "id": 26450,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Implantable cardioverter-defibrillator (ICD) </span></span></span></p>"
        },
        {
          "id": 26451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Implantable pulmonary artery pressure sensor </span></span></span></p>"
        },
        {
          "id": 26452,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wearable cardioverter-defibrillator</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 63-year-old man who is a known case of HFrEF presents with persistent NYHA III symptoms despite optimal medical therapy. ECG shows LBBB and echo shows an EF of 25%. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q1009068",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974423,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Cardiac resynchronization therapy-defibrillator (CRT-D)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CRT-D is indicated in patients with HFrEF (EF &le; 35%), LBBB with QRS duration &ge; 150 ms (or 120-149 ms in some cases), and NYHA class II-IV symptoms despite optimal medical therapy. CRT improves symptoms and survival, and the defibrillator component provides protection against sudden cardiac death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. ICD:</span></strong><span style=\"font-size:12.0pt\"> May be indicated for primary prevention of sudden cardiac death but doesn&#39;t address the LBBB and dyssynchrony. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Implantable pulmonary artery pressure sensor:</span></strong><span style=\"font-size:12.0pt\"> Used for monitoring, not for treating heart failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Wearable cardioverter-defibrillator:</span></strong><span style=\"font-size:12.0pt\"> Temporary measure, not appropriate for long-term management of heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac resynchronization therapy is indicated in patients with New York Heart Association functional class II to IV symptoms despite guideline-directed medical therapy who have an ejection fraction of 35% or less, sinus rhythm, and left bundle branch block with a QRS duration of 150 ms or longer.</span></span></p>",
      "correct_choice_id": 26449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7080,
      "choices": [
        {
          "id": 28288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrioventricular (AV) node ablation with permanent pacemaker implantation</span></span></span></p>"
        },
        {
          "id": 28289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Implantable cardioverter-defibrillator (ICD) placement </span></span></span></p>"
        },
        {
          "id": 28290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left atrial appendage occlusion (LAAO)</span></span></span></p>"
        },
        {
          "id": 28291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rhythm control</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old woman with paroxysmal AF and HFrEF (EF 45%) has recurrent hospitalizations due to acute heart failure. She is currently on apixaban, metoprolol, furosemide, and telmisartan. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q8695744",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974424,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Rhythm control</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aggressive rhythm control (with antiarrhythmic drugs or catheter ablation) has been shown to reduce morbidity and mortality in patients with HF and AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with HFrEF, recent clinical trials have shown that catheter ablation of AF is associated with a favorable effect on morbidity and mortality compared with medical therapy. Amiodarone is another option for rhythm control. Although amiodarone carries a risk for toxicity, this patient&#39;s lifetime exposure to the drug is likely to be relatively low given her age, comorbid conditions, and probable amiodarone dosage, which is generally lower for AF than for ventricular arrhythmias. Monitored appropriately, it can be used safely and effectively in patients her age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. AV node ablation:</span></strong><span style=\"font-size:12.0pt\"> Considered only if rate and rhythm control fails to control tachycardia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. ICD:</span></strong><span style=\"font-size:12.0pt\"> Indicated for primary prevention of sudden cardiac death in certain patients, but not the primary treatment for this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. LAAO:</span></strong><span style=\"font-size:12.0pt\"> Used for stroke prevention in patients who have C/I for anticoagulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aggressive efforts to achieve rhythm control in patients with atrial fibrillation and concomitant heart failure decrease morbidity and mortality.</span></span></p>",
      "correct_choice_id": 28291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7083,
      "choices": [
        {
          "id": 28300,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis</span></p>"
        },
        {
          "id": 28301,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 28302,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart failure with reduced ejection fraction</span></p>"
        },
        {
          "id": 28303,
          "text": "<p><span style=\"font-size:12.0pt;\">Large pericardial effusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 69-year-old woman is evaluated in the emergency department for a 1-week history of progressive exertional dyspnea and orthopnea. Vital signs are normal. Focused point-of-care cardiac ultrasonography is performed and done and as shown below. Which of the following is the most likely&nbsp;diagnosis?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/supawork-e53ff9bb04dd417abdf7b818ed4326bc.gif\" width=\"600\" height=\"406\"></p>",
      "unique_key": "Q4189323",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974425,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Heart failure with reduced ejection fraction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heart failure with reduced ejection fraction (HFrEF) is characterized by a reduced left ventricular ejection fraction (LVEF), typically &lt;40%, as seen in the ultrasonographic findings. Symptoms such as progressive exertional dyspnea and orthopnea are hallmark clinical manifestations of left-sided heart failure, commonly due to impaired myocardial contractility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic stenosis</strong>: Aortic stenosis typically presents with symptoms such as chest pain, syncope, and heart failure. However, the ultrasound findings do not suggest aortic valve pathology or significant left ventricular outflow obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cardiac tamponade</strong>: Cardiac tamponade would present with findings such as hypotension, jugular venous distension, and pulsus paradoxus. The ultrasound in tamponade typically shows a large pericardial effusion with diastolic collapse of the right atrium or right ventricle. These findings are not present in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Large pericardial effusion</strong>: A large pericardial effusion would show a significant fluid accumulation around the heart on ultrasound, often leading to tamponade physiology. This is not observed in the provided ultrasound image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the clinical presentation of heart failure with reduced ejection fraction (HFrEF) and correlate it with echocardiographic findings, emphasizing the importance of identifying left ventricular systolic dysfunction in patients presenting with symptoms of heart failure.</span></p>",
      "correct_choice_id": 28302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7087,
      "choices": [
        {
          "id": 28316,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Cardiac tamponade</span></span></span></p>"
        },
        {
          "id": 28317,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Eosinophilic pneumonia</span></span></span></p>"
        },
        {
          "id": 28318,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphangioleiomyomatosis</span></span></span></p>"
        },
        {
          "id": 28319,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man is evaluated in the emergency department for acute worsening of dyspnea. Chest radiograph is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/screenshot-2024-08-09-115748.jpg\" style=\"height:370px; width:400px\" /></span></span></p>",
      "unique_key": "Q4234359",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974426,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Pulmonary edema</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient&#39;s chest radiograph shows cardiomegaly and bilateral perihilar alveolar infiltrates, consistent with a diagnosis of pulmonary edema due to heart failure. A small left pleural effusion is seen, as well as fluid in the minor fissure, also consistent with heart failure. Although cardiomegaly can be seen in tamponade, diffuse alveolar infiltrates are not a feature of this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cardiac tamponade</span></strong><span style=\"font-size:12.0pt\">: While cardiomegaly can be seen in cardiac tamponade, which is a condition where fluid accumulates in the sac surrounding the heart, leading to compression of the heart, diffuse alveolar infiltrates are not a feature of cardiac tamponade. Therefore, this diagnosis is unlikely based on the radiographic findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Eosinophilic pneumonia</span></strong><span style=\"font-size:12.0pt\">: Eosinophilic pneumonia is characterized by the presence of eosinophils (a type of white blood cell) in the lung tissue, which typically presents with bilateral infiltrates on a chest radiograph. However, this condition does not usually present with cardiomegaly or pleural effusion, making this option less likely given the findings on the radiograph.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C. Lymphangioleiomyomatosis:</strong> Lymphangioleiomyomatosis is a rare lung disease that affects the lungs and lymphatic system, leading to cystic lung disease. The chest radiograph for this condition would typically show diffuse thin-walled cysts rather than cardiomegaly, alveolar infiltrates, or pleural effusion. Thus, this diagnosis is inconsistent with the radiographic findings in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary edema is characterized by cardiomegaly and bilateral perihilar alveolar infiltrates on a chest radiograph, often associated with pleural effusion and fluid in the minor fissure, especially in the context of heart failure. This is a key diagnostic feature that must be remembered.</span></span></span></p>",
      "correct_choice_id": 28319,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7088,
      "choices": [
        {
          "id": 28320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage A </span></span></span></p>"
        },
        {
          "id": 28321,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage B </span></span></span></p>"
        },
        {
          "id": 28322,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage C </span></span></span></p>"
        },
        {
          "id": 28323,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stage D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old man with a past medical history of coronary artery disease develops a myocardial infarction. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. Repeat Echo after 3 months shows the same findings. What is this patient&rsquo;s heart failure stage?</span></span></span></p>",
      "unique_key": "Q6574719",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974427,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Stage B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has structural heart disease (reduced ejection fraction due to prior myocardial infarction) but no current symptoms of heart failure. This places him in <strong>Stage B</strong> heart failure according to the American College of Cardiology/American Heart Association (ACC/AHA) classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Stage A:</span></strong><span style=\"font-size:12.0pt\"> Patients in Stage A have risk factors for HF but no structural heart disease or symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Stage C:</span></strong><span style=\"font-size:12.0pt\"> Patients in Stage C have structural heart disease and current or prior symptoms of HF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Stage D:</span></strong><span style=\"font-size:12.0pt\"> Patients in Stage D have refractory HF requiring specialized interventions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACC/AHA staging system for heart failure, categorizes patients based on the presence or absence of structural heart disease and symptoms of heart failure. </span></span></p>",
      "correct_choice_id": 28321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7090,
      "choices": [
        {
          "id": 28328,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Constrictive pericarditis </span></span></span></p>"
        },
        {
          "id": 28329,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fabry disease </span></span></span></p>"
        },
        {
          "id": 28330,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dilated Cardiomyopathy </span></span></span></p>"
        },
        {
          "id": 28331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Restrictive cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 64-year-old woman with a history of recurrent heart failure hospitalizations presents with ascites and edema. Her JVP was elevated and there was no change with inspiration. On examination, she has an audible low-pitched late diastolic sound with a pansystolic murmur in the left sternal border. Echo shows diastolic dysfunction with mildly increased LV wall thickness. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2519408",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Restrictive cardiomyopathy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ascites and edema:</span></strong><span style=\"font-size:12.0pt\"> These are signs of right heart failure, which can be a consequence of RCM due to increased left atrial pressure.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Elevated JVP with no inspiratory decline:</span></strong><span style=\"font-size:12.0pt\"> This finding, known as Kussmaul&#39;s sign, is suggestive of impaired right ventricular filling, seen in RCM and constrictive pericarditis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low-pitched late diastolic sound (S4):</span></strong><span style=\"font-size:12.0pt\"> This is a hallmark of RCM and indicates diastolic dysfunction/ stiff ventricle. Patients can have S3 as well. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pansystolic murmur at the left sternal border:</span></strong><span style=\"font-size:12.0pt\"> This suggests tricuspid regurgitation, a common complication of RCM due to right ventricular dilatation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Echo findings:</span></strong><span style=\"font-size:12.0pt\"> Diastolic dysfunction with mildly increased LV wall thickness is typical of RCM.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Constrictive pericarditis:</span></strong><span style=\"font-size:12.0pt\"> While this can also cause elevated JVP and diastolic dysfunction, it usually does not present with a pansystolic murmur or S3 gallop. Pericardial knock is more characteristic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Fabry disease:</span></strong><span style=\"font-size:12.0pt\"> This is a rare genetic disorder that can cause RCM, but it is less likely than other causes in this patient without a specific family history or other suggestive features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dilated cardiomyopathy:</span></strong><span style=\"font-size:12.0pt\"> This presents with systolic dysfunction (reduced ejection fraction) and a dilated left ventricle, which are not seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restrictive cardiomyopathy presents with features of right heart failure, Kussmaul&#39;s sign, S3/S4 gallop, diastolic dysfunction, and associated findings like TR.</span></span></p>",
      "correct_choice_id": 28331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7114,
      "choices": [
        {
          "id": 28424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sacubitril-Valsartan </span></span></span></p>"
        },
        {
          "id": 28425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Empagliflozin </span></span></span></p>"
        },
        {
          "id": 28426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spironolactone </span></span></span></p>"
        },
        {
          "id": 28427,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man presents with dyspnea on exertion. His resting ECG is normal. 2D echo revealed diastolic dysfunction, mild concentric LVH, and an LV EF of 65%. His BNP levels were elevated. Which of the following will maximally increase survival in this patient?</span></span></p>",
      "unique_key": "Q1391346",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) None of the above</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation is consistent with heart failure with preserved ejection fraction (HFpEF). Currently, there are no medications proven to significantly reduce mortality in HFpEF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The medications listed (Sacubitril-Valsartan, Empagliflozin, Spironolactone) are primarily used for heart failure with reduced ejection fraction (HFrEF), where they have shown mortality benefits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Sacubitril-Valsartan:</span></strong><span style=\"font-size:12.0pt\"> This is an angiotensin receptor-neprilysin inhibitor (ARNI) indicated for HFrEF, not HFpEF. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Empagliflozin:</span></strong><span style=\"font-size:12.0pt\"> This is an SGLT2 inhibitor shown to benefit patients with HFrEF and may reduce hospitalizations in HFpEF, but not proven to improve survival. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Spironolactone:</span></strong><span style=\"font-size:12.0pt\"> While this mineralocorticoid receptor antagonist may improve symptoms and reduce hospitalizations in HFpEF, it has not been shown to reduce mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There are no medications currently proven to significantly improve survival in HFpEF. Management primarily focuses on symptom management. </span></span></span></p>",
      "correct_choice_id": 28427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7121,
      "choices": [
        {
          "id": 28452,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Class I </span></span></span></p>"
        },
        {
          "id": 28453,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Class II </span></span></span></p>"
        },
        {
          "id": 28454,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Class III </span></span></span></p>"
        },
        {
          "id": 28455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Class IV </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old man with a history of MI and HF is comfortable at rest. However, when walking to his car, he develops dyspnea, fatigue, and sometimes palpitations. He must rest for several minutes before these symptoms resolve. Which of the following is his NYHA classification?</span></span></span></p>",
      "unique_key": "Q4923981",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974430,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Class III</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The New York Heart Association (NYHA) classification is a system used to categorize the severity of heart failure based on the patient&#39;s functional capacity and symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Class III:</span></strong><span style=\"font-size:12.0pt\"> Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, dyspnea, or angina.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient in this case experiences symptoms with mild exertion (walking to his car) but is comfortable at rest, indicating a marked limitation of activity. Therefore, he falls into <strong>NYHA Class III</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Class I:</span></strong><span style=\"font-size:12.0pt\"> No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea (shortness of breath), or angina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Class II:</span></strong><span style=\"font-size:12.0pt\"> Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, palpitation, dyspnea, or angina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Class IV:</span></strong><span style=\"font-size:12.0pt\"> Unable to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest. If any physical activity is undertaken, discomfort is increased.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the NYHA classification, Class III heart failure is defined by marked limitation of physical activity where patients are comfortable at rest, but less than ordinary activity (e.g., walking short distances) causes symptoms such as dyspnea, fatigue, and palpitations.</span></span></p>",
      "correct_choice_id": 28454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11327,
      "choices": [
        {
          "id": 45274,
          "text": "<p><span style=\"font-size:12.0pt;\">Add intravenous enalaprilat</span></p>"
        },
        {
          "id": 45275,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase nitroprusside infusion</span></p>"
        },
        {
          "id": 45276,
          "text": "<p><span style=\"font-size:12.0pt;\">Repair the descending aorta</span></p>"
        },
        {
          "id": 45277,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch nitroprusside to amlodipine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman with a recent type B aortic dissection presents with abdominal pain and lower limb ischemia with diminished femoral and popliteal pulses. What is the most appropriate next step?</span></p>",
      "unique_key": "Q2369929",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974431,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Repair the descending aorta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">New-onset abdominal pain and limb ischemia in a patient with type B aortic dissection indicate a complicated dissection, likely due to malperfusion of the mesenteric and lower extremity arteries. This requires urgent surgical or endovascular repair.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Enalaprilat:</strong> Although used for blood pressure control, it doesn't address the underlying issue of malperfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increasing nitroprusside:</strong> May help with blood pressure control but doesn't solve the urgent need for revascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. &nbsp;Switching to amlodipine:</strong> Not appropriate in an acute setting requiring immediate intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the signs of complicated type B aortic dissection (malperfusion syndromes) and the need for immediate surgical/endovascular repair.</span></p>",
      "correct_choice_id": 45276,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19811,
      "choices": [
        {
          "id": 79205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Add atorvastatin</span></span></span></p>"
        },
        {
          "id": 79206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Add losartan</span></span></span></p>"
        },
        {
          "id": 79207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic repair before pregnancy</span></span></span></p>"
        },
        {
          "id": 79208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proceed with pregnancy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman with Marfan syndrome has an ascending aortic diameter of 4.3 cm, which has increased by 0.6 cm in the past year. Her mother had an aortic dissection. She is considering pregnancy. What is the most appropriate management?</span></span></p>",
      "unique_key": "Q1720001",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974432,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Aortic repair before pregnancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients with Marfan syndrome have an increased risk of aortic dissection during pregnancy. Aortic repair is recommended before pregnancy in patients with aortic root dilation &gt;4.0 cm and risk factors like family history or rapid aneurysm growth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atorvastatin:</span></strong><span style=\"font-size:12.0pt\"> Statins are not indicated for aortic disease management in this context and are contraindicated in pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. &nbsp;Losartan:</span></strong><span style=\"font-size:12.0pt\"> Contraindicated in pregnancy due to fetal toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> &nbsp;Proceeding with pregnancy without aortic repair would be dangerous due to the high risk of dissection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Patients with Marfan syndrome have an increased risk for pregnancy-related aortic dissection and rupture; aortic repair surgery is recommended before conception to reduce this risk in those with an ascending aortic diameter greater than 4.0 cm and who have risk factors for aortic dissection.</span></span></span></p>",
      "correct_choice_id": 79207,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19815,
      "choices": [
        {
          "id": 79221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute coronary syndrome</span></span></span></p>"
        },
        {
          "id": 79222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic dissection</span></span></span></p>"
        },
        {
          "id": 79223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism</span></span></span></p>"
        },
        {
          "id": 79224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stress-induced cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 73-year-old woman with extensive cardiovascular disease and poorly controlled hypertension is evaluated for acute-onset ripping chest pain that radiates to her back. Chest radiograph is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/09/untitled-3.jpg\" style=\"height:300px; width:300px\" /></span></span></p>",
      "unique_key": "Q5269498",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Aortic dissection</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is acute aortic dissection. This patient&#39;s chest radiograph shows a widened superior mediastinum and a right pleural effusion consistent with aortic dissection, although these findings are not diagnostic. The diagnosis of aortic dissection can be established with transesophageal echocardiography, CT angiography, or MR angiography, all of which have similar sensitivity and specificity for acute thoracic aortic disease. Because of its wide availability and short image acquisition time, CT angiography has become the primary diagnostic test for acute thoracic aortic disease.</span></span></span></p>",
      "correct_choice_id": 79222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6578,
      "choices": [
        {
          "id": 26281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left anterior descending (LAD) artery </span></span></span></p>"
        },
        {
          "id": 26282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left circumflex (LCx) artery </span></span></span></p>"
        },
        {
          "id": 26283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right coronary artery (RCA) </span></span></span></p>"
        },
        {
          "id": 26284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left main coronary artery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with a history of hypertension and hyperlipidemia presents with acute chest pain radiating to the left arm and jaw. ECG is shown. Which coronary artery is most likely occluded?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-174647.png\" style=\"height:143px; width:400px\" /></span></span></p>",
      "unique_key": "Q6215481",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974434,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Right coronary artery (RCA)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ST-segment elevation in leads II, III, and aVF is indicative of an inferior myocardial infarction, which is most commonly caused by occlusion of the RCA. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">(This patient also has ST elevations in V1/V2 which may indicate RV infarction. However V4R is needed to confirm this).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Explanation</u>:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Left anterior descending (LAD) artery</span></strong><span style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">Occlusion of the LAD artery typically causes ST-segment elevation in anterior leads. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Left circumflex (LCx) artery</span></strong><span style=\"font-size:12.0pt\">:</span><strong> </strong><span style=\"font-size:12.0pt\">Occlusion of the LCx artery typically causes ST-segment elevation in lateral leads. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Left main coronary artery</span></strong><span style=\"font-size:12.0pt\">: </span><span style=\"font-size:12.0pt\">Occlusion of the left main coronary artery typically causes widespread ST-segment elevation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Educational Objective</u>:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognize the ECG findings of an inferior myocardial infarction and its association with RCA occlusion.</span></span></span></p>",
      "correct_choice_id": 26283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6581,
      "choices": [
        {
          "id": 26293,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized cardioversion</span></p>"
        },
        {
          "id": 26294,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat adenosine</span></p>"
        },
        {
          "id": 26295,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoptolol</span></p>"
        },
        {
          "id": 26296,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman presents with recurrent palpitations and near-syncope. ECG during the episode is shown. His BP is 130/84 mm Hg and PR is 154/min. Vagal manoeuvrers and IV adenosine (6mg) administration do not terminate the tachycardia. What is the most appropriate next step in management?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175001.png\" alt=\"\" width=\"400\" height=\"227\"></span></p>",
      "unique_key": "Q9365643",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>B) Repeat Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a hemodynamically stable patient with AVNRT, the next step after a failed initial dose of adenosine (6 mg) is to repeat adenosine at a higher dose of 12 mg IV push.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine is a short-acting AV nodal blocker that can effectively terminate AVNRT. The initial dose may not be sufficient in some cases, and a second dose (or even a third dose) is often successful.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Synchronized cardioversion:</strong> This is typically reserved for hemodynamically unstable patients or those who fail medical therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metoprolol:</strong> Beta-blockers like metoprolol (and calcium channel blockers) are used if initial therapy with vagal manoeuvres and adenosine fail.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amiodarone:</strong> This is an antiarrhythmic drug that can be used if AV nodal blockers fail.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Step wise management of regular narrow complex tachycardia (like AVNRT):</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-175104.png\" alt=\"\" width=\"500\" height=\"540\"></span></p>",
      "correct_choice_id": 26294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6583,
      "choices": [
        {
          "id": 26301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brugada syndrome </span></span></span></p>"
        },
        {
          "id": 26302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Congenital long QT syndrome </span></span></span></p>"
        },
        {
          "id": 26303,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wolff-Parkinson-White syndrome</span></span></span></p>"
        },
        {
          "id": 26304,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophic cardiomyopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old intern presents with recurrent episodes of syncope after hearing ambulance siren in the ER. She also experiences light-headedness and dizziness early morning once she wakes up hearing alarms. The ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180215.png\" style=\"height:242px; width:400px\" /></span></span></p>",
      "unique_key": "Q1244645",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974436,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Congenital long QT syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Congenital long QT syndrome (LQTS) is a genetic disorder characterized by a prolonged QT interval on the ECG (like in this ECG). LQTS can cause syncope, particularly in response to emotional or auditory stimuli (like the ambulance sirens in this case). This patient&#39;s presentation aligns with LQT2, a subtype of LQTS often triggered by sudden noises.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brugada syndrome:</span></strong><span style=\"font-size:12.0pt\"> This is associated with a specific ECG pattern (ST-elevation in V1-V3) and sudden cardiac death, not typically triggered by sounds.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Wolff-Parkinson-White syndrome:</span></strong><span style=\"font-size:12.0pt\"> This involves an accessory pathway, causing a short PR interval and delta wave, and is not typically associated with syncope triggered by sound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypertrophic cardiomyopathy:</span></strong><span style=\"font-size:12.0pt\"> This is characterized by left ventricular hypertrophy, which may or may not have a prolonged QT interval and is not typically triggered by sound.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syncope triggered by auditory stimuli, combined with a prolonged QT interval on ECG, is highly suggestive of congenital long QT syndrome, particularly LQT2. </span></span></span></p>",
      "correct_choice_id": 26302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6585,
      "choices": [
        {
          "id": 26309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial fibrillation </span></span></span></p>"
        },
        {
          "id": 26310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial tachycardia </span></span></span></p>"
        },
        {
          "id": 26311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrioventricular nodal reentrant tachycardia (AVNRT) </span></span></span></p>"
        },
        {
          "id": 26312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 42-year-old woman presents with abrupt-onset palpitations that she can terminate by coughing. ECG is shown. What is the most likely rhythm diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180707.png\" style=\"height:211px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q5148909",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Atrioventricular nodal reentrant tachycardia (AVNRT)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AVNRT is the most common type of paroxysmal supraventricular tachycardia. It presents with abrupt onset and termination, a narrow QRS complex tachycardia, and often responds to vagal maneuvers like coughing. The pseudo r&#39; wave in V1 is a characteristic ECG finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-180802.png\" style=\"height:170px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Atrial fibrillation:</span></strong><span style=\"font-size:12.0pt\"> Irregular rhythm with no discernible P waves. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atrial tachycardia:</span></strong><span style=\"font-size:12.0pt\"> Typically slower than AVNRT and less likely to be terminated by vagal maneuvers. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular tachycardia:</span></strong><span style=\"font-size:12.0pt\"> Wide QRS complex tachycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;ECG findings of AVNRT = narrow QRS complex tachycardia, pseudo r&#39; wave in V1, and responsiveness to vagal maneuvers. </span></span></span></p>",
      "correct_choice_id": 26311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6600,
      "choices": [
        {
          "id": 26369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accelerated idioventricular rhythm</span></span></span></p>"
        },
        {
          "id": 26370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left bundle branch block</span></span></span></p>"
        },
        {
          "id": 26371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Old inferior myocardial infarction</span></span></span></p>"
        },
        {
          "id": 26372,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right bundle branch block</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 61-year-old man is evaluated following the recent diagnosis of hypertension. ECG is shown. Which of the following abnormalities is seen on this patient&#39;s ECG?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-181851.png\" style=\"height:128px; width:300px\" /></span></span></p>",
      "unique_key": "Q6507737",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Left bundle branch block</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG demonstrates left bundle branch block. Left bundle branch block is characterized by the following features: (1) QRS widening of at least 120 ms, (2) upright monophasic QRS complex in leads I and V6 (the QRS complex may also be notched), and (3) a predominantly negative QRS complex in lead V1. In the ECG shown, all three features are evident. In both left and right bundle branch block, the ST-T&ndash;wave pattern is inscribed in the opposite direction of the main QRS vectors; these ST-T&ndash;wave abnormalities are secondary to the bundle branch block and do not indicate additional underlying pathology.</span></span></span></p>",
      "correct_choice_id": 26370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6606,
      "choices": [
        {
          "id": 26393,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial fibrillation</span></span></span></p>"
        },
        {
          "id": 26394,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial flutter</span></span></span></p>"
        },
        {
          "id": 26395,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial tachycardia</span></span></span></p>"
        },
        {
          "id": 26396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sinus tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman is evaluated for palpitations. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#39;s ECG?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182715.png\" style=\"height:213px; width:400px\" /></span></span></p>",
      "unique_key": "Q6707807",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974439,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><strong><span style=\"font-size:12.0pt\"> B) Atrial flutter</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG demonstrates atrial flutter, which is characterized by a regular atrial rate that is often close to 300/min and by a sawtooth pattern. Flutter waves are most easily seen in the inferior leads (II, III, and aVF) and lead V1. Most commonly, there is 2:1 conduction to the ventricles, resulting in a ventricular rate of approximately 150/min, as seen in the first part of this tracing. A 4:1 conduction pattern with a rate of 75/min is also seen.</span></span></span></p>",
      "correct_choice_id": 26394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19835,
      "choices": [
        {
          "id": 79301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothyroidism</span></span></span></p>"
        },
        {
          "id": 79302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infiltrative cardiomyopathy</span></span></span></p>"
        },
        {
          "id": 79303,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pericardial effusion</span></span></span></p>"
        },
        {
          "id": 79304,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stress-related cardiomyopathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 49-year-old man is evaluated for symptoms of dyspnea, peripheral edema, and exercise intolerance. Echocardiography shows biventricular increased wall thickness. ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-182906.png\" style=\"height:216px; width:400px\" /></span></span></p>",
      "unique_key": "Q3522474",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974440,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">B) Infiltrative cardiomyopathy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is an infiltrative cardiomyopathy, such as cardiac amyloidosis. This ECG demonstrates low voltage with QRS amplitude of less than 5 mm in the limb leads. Low voltage may also be demonstrated by a QRS amplitude of less than 10 mm in the precordial leads. When low ECG voltage accompanies increased wall thickness on echocardiogram, an infiltrative cardiomyopathy, such as amyloidosis, should be considered. Serum protein electrophoresis/urine protein electrophoresis and free light-chain analysis may help identify immunoglobulin light-chain amyloidosis.</span></span></span></p>",
      "correct_choice_id": 79302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60044,
      "choices": [
        {
          "id": 239477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arrhythmogenic right ventricular cardiomyopathy/dysplasia</span></span></span></p>"
        },
        {
          "id": 239478,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brugada syndrome</span></span></span></p>"
        },
        {
          "id": 239479,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pericarditis</span></span></span></p>"
        },
        {
          "id": 239480,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary embolism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man is evaluated for the acute onset of severe chest pain. ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183237.png\" style=\"height:214px; width:400px\" /></span></span></p>",
      "unique_key": "Q5244425",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974441,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Pericarditis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is pericarditis. Electrocardiographic changes characteristic of acute pericarditis include diffuse ST-segment elevations and a depressed PR interval, both of which are present in this patient&#39;s ECG; leads I and II in this ECG demonstrate a depressed PR interval, most notably in the lead II rhythm strip. As pericarditis evolves, the electrocardiographic manifestations change and are classified into stages: Stage 1 is characterized by diffuse ST-segment elevations; stage 2, by &ldquo;pseudonormalization,&rdquo; in which the ST segments normalize; stage 3, by diffuse T-wave inversion and possible slightly depressed ST segments; and stage 4, by a return to normal on ECG.</span></span></span></p>",
      "correct_choice_id": 239479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60045,
      "choices": [
        {
          "id": 239481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antidromic atrioventricular reentrant tachycardia</span></span></span></p>"
        },
        {
          "id": 239482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial tachycardia</span></span></span></p>"
        },
        {
          "id": 239483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrioventricular nodal reentrant tachycardia</span></span></span></p>"
        },
        {
          "id": 239484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sinus tachycardia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man is evaluated for palpations and light headedness. ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-183439.png\" style=\"height:211px; width:400px\" /></span></span></p>",
      "unique_key": "Q4327406",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974442,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Atrioventricular nodal reentrant tachycardia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;This ECG demonstrates atrioventricular nodal reentrant tachycardia (AVNRT). AVNRT accounts for two thirds of all supraventricular tachycardias. Patients with AVNRT have two electrical conduction pathways that are proximal to or within the atrioventricular node. One pathway conducts the electrical impulse rapidly but has a prolonged refractory period (fast pathway), and the second has slower conduction but a short refractory period (slow pathway). During sinus conduction, the impulse travels down both pathways; however, electrical conduction down the slow pathway is blocked at or below the level of the atrioventricular node because of the &ldquo;refractory wave&rdquo; produced by the previous electrical conduction down the fast pathway. If a premature beat is correctly timed, the conduction can travel down the slow pathway to activate the ventricles and retrograde up the fast pathway to activate the atria, thus creating a circuit and a sustained tachycardia with a ventricular rate between 120/min and 220/min. In the most common variety of AVNRT, the P wave is buried in the QRS complex or a portion of the P wave can be discerned, altering the morphology of the QRS complex. In the accompanying ECG, the P waves are hidden within the QRS complex, indicating AVNRT. In both atrial tachycardia and sinus tachycardia, P waves are visible; in antidromic atrioventricular reentrant tachycardia, the QRS complex is wide owing to impulse conduction over the bypass tract and outside the normal conduction system in the ventricles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 239483,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60048,
      "choices": [
        {
          "id": 239493,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Junctional rhythm</span></span></span></p>"
        },
        {
          "id": 239494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Monomorphic ventricular tachycardia</span></span></span></p>"
        },
        {
          "id": 239495,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polymorphic ventricular tachycardia</span></span></span></p>"
        },
        {
          "id": 239496,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular fibrillation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old woman with sarcoidosis is evaluated for an irregular pulse, a sensation of pounding in the neck, and an episode of syncope. ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184202.png\" style=\"height:212px; width:400px\" /></span></span></p>",
      "unique_key": "Q9197161",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Monomorphic ventricular tachycardia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG shows ventricular tachycardia, which is typically caused by organic heart disease. It begins approximately one third of the way into the tracing and is marked by an abrupt change in axis and widening of the QRS complex. Ventricular tachycardia is characterized by fairly regular wide QRS complexes, a pulse rate of more than 120/min, and atrioventricular dissociation. Ventricular tachycardia can be characterized as either sustained (lasting &gt;30 seconds) or nonsustained, and as monomorphic, if all of the QRS complexes have the same morphology, or as polymorphic, if the QRS pattern twists across the baseline (e.g., torsades de pointes). Ventricular tachycardia can degenerate into ventricular fibrillation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 239494,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60049,
      "choices": [
        {
          "id": 239497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ostium primum atrial septal defect</span></span></span></p>"
        },
        {
          "id": 239498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 239499,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent foramen ovale</span></span></span></p>"
        },
        {
          "id": 239500,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular septal defect</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old woman is evaluated for unexplained right heart enlargement and a history of paroxysmal atrial fibrillation. Physical examination reveals a parasternal impulse, fixed splitting of S2, mitral regurgitation, and a pulmonary outflow murmur. ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184317.png\" style=\"height:179px; width:400px\" /></span></span></p>",
      "unique_key": "Q4590448",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974444,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>A) Ostium primum atrial septal defect</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most likely diagnosis is ostium primum atrial septal defect (ASD). This ECG demonstrates the typical findings in ostium primum ASD, including left axis deviation, first-degree atrioventricular block, and right bundle branch block. Located in the lowest portion of the atrial septum, ostium primum ASD (15%-20% of ASDs) are a component of endocardial cushion defects. Associated abnormalities include mitral valve, ventricular septum, and subaortic anomalies. Clinical findings in patients with an ASD include a parasternal impulse, fixed splitting of the S2, and a pulmonary outflow murmur. A diastolic flow rumble across the tricuspid valve can occur with a large left-to-right shunt.</span></span></span></p>",
      "correct_choice_id": 239497,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60050,
      "choices": [
        {
          "id": 239501,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial tachycardia with 2:1 block</span></span></span></p>"
        },
        {
          "id": 239502,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complete heart block</span></span></span></p>"
        },
        {
          "id": 239503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Junctional rhythm</span></span></span></p>"
        },
        {
          "id": 239504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mobitz type 2 second-degree atrioventricular block</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 64-year-old woman is evaluated in the emergency department following an episode of syncope. ECG is shown. Which of the following abnormalities is demonstrated on this patient&#39;s ECG?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184453.png\" style=\"height:210px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q4458388",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974445,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Junctional rhythm</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ECG shown demonstrates a junctional rhythm, or atrioventricular nodal rhythm. Junctional rhythms are regular supraventricular rhythms in which the P wave in lead II is negative (preceding or following the QRS complex) or absent (arrows). An atrioventricular nodal escape rhythm occurs when the junctional rate is between 40/min and 60/min and the sinoatrial node is delayed or fails to function as the pacemaker. An accelerated junctional rhythm occurs when the junctional rate is between 61/min and 99/min and the junctional rate takes over the pacemaker function. Junctional tachycardia occurs when the junctional rate is faster than 99/min and takes over the pacemaker function.</span></span></span></p>",
      "correct_choice_id": 239503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60051,
      "choices": [
        {
          "id": 239505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Monomorphic ventricular tachycardia</span></span></span></p>"
        },
        {
          "id": 239506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right bundle branch block with aberrancy</span></span></span></p>"
        },
        {
          "id": 239507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Torsades de pointes</span></span></span></p>"
        },
        {
          "id": 239508,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ventricular fibrillation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man is evaluated in the emergency department for rapid heart rate and dizziness. He was recently started on levofloxacin for community-acquired pneumonia. A telemetry rhythm strip is shown. Which of the following abnormalities is seen on this patient&#39;s telemetry rhythm strip?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-184630.png\" style=\"height:86px; width:400px\" /></span></span></p>",
      "unique_key": "Q8383021",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Torsades de pointes</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient&#39;s telemetry rhythm strip demonstrates torsades de pointes, a polymorphic ventricular tachycardia. The torsades de pointes pattern is associated with QT interval prolongation and is characterized by an undulating QRS pattern that seems to twist across the baseline. This tracing also shows the initiation of ventricular tachycardia with a premature ventricular complex occurring during the repolarization phase of the previous QRS complex (&ldquo;R-on-T&rdquo; event). Macrolides and quinolones may prolong the QT interval, and alternative agents should be considered in patients at risk for torsades de pointes, including history of a long QT interval or use of other medications that prolong the QT interval.</span></span></span></p>",
      "correct_choice_id": 239507,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60054,
      "choices": [
        {
          "id": 239517,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brugada syndrome</span></span></span></p>"
        },
        {
          "id": 239518,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertrophic cardiomyopathy</span></span></span></p>"
        },
        {
          "id": 239519,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Long QT syndrome</span></span></span></p>"
        },
        {
          "id": 239520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neurocardiogenic syncope</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old woman is evaluated for recurrent episodes of syncope. She is otherwise well and takes no medications. ECG is shown. Which of the following is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185143.png\" style=\"height:224px; width:400px\" /></span></span></p>",
      "unique_key": "Q4327994",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974447,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Long QT syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG demonstrates long QT syndrome. A quick way to assess whether the QT interval is prolonged is to note whether the QT interval exceeds half of the R-R interval, as is evident in this patient&#39;s ECG. The QT interval depends on heart rate; if the heart rate is between 60/min and 100/min, the corrected QT interval (QTc) is determined by dividing the actual QT interval by the square root of the R-R interval (in seconds). QTc intervals of 450 ms or less in men and 460 ms or less in women are considered normal. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Long QT syndrome can be acquired or congenital. In adults, the most common causes are drugs, including methadone, fluoroquinolones, antiarrhythmics, and psychotropics.</span></span></span></p>",
      "correct_choice_id": 239519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60055,
      "choices": [
        {
          "id": 239521,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idioventricular rhythm</span></span></span></p>"
        },
        {
          "id": 239522,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mobitz type 2 second-degree heart block</span></span></span></p>"
        },
        {
          "id": 239523,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sinus bradycardia</span></span></span></p>"
        },
        {
          "id": 239524,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Third-degree heart block</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 79-year-old woman is evaluated for fatigue and bradycardia. ECG is shown. Which of the following abnormalities is seen on this patient&#39;s ECG?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185318.png\" style=\"height:144px; width:400px\" /></span></span></p>",
      "unique_key": "Q4496773",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974448,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>D) Third-degree heart block</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;This ECG demonstrates third-degree heart block, which is characterized electrocardiographically by dissociation between the P waves and the QRS complexes. P waves discharge at their inherent rate but cannot be conducted to the ventricles. If the QRS complexes are narrow, the heart block is usually at the level of the His bundle. If the QRS complexes are wide, the heart block is lower (below the His bundle), and the rate will be between 30/min and 40/min.</span></span></span></p>",
      "correct_choice_id": 239524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60056,
      "choices": [
        {
          "id": 239525,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial septal defect</span></span></span></p>"
        },
        {
          "id": 239526,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lown-Ganong-Levine pattern</span></span></span></p>"
        },
        {
          "id": 239527,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patent foramen ovale</span></span></span></p>"
        },
        {
          "id": 239528,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wolff-Parkinson-White pattern</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 31-year-old woman is evaluated for episodes of palpitations. ECG is shown. Which of the following abnormalities or underlying conditions is responsible for the changes on this patient&#39;s ECG?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185505.png\" style=\"height:211px; width:400px\" /></span></span></p>",
      "unique_key": "Q4878876",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974449,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>D) Wolff-Parkinson-White pattern</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wolff-Parkinson-White pattern, which is characterized by QRS widening, a delta wave, and a short PR interval, is responsible for the findings on this patient&#39;s ECG. In Wolff-Parkinson-White pattern, an accessory pathway bypasses the atrioventricular node and causes preexcitation, resulting in the short PR interval and delta wave at the beginning of the QRS complex. In this ECG, positive delta waves (initial upsloping of the QRS complex) with a short PR interval are seen in leads I, II, and aVL and precordial leads V2 through V6. Negative delta waves (an initial negative deflection) are seen in leads III, aVF, and aVR, giving the appearance of an inferior infarct pattern. Patients with evidence of preexcitation on their resting ECG and symptomatic supraventricular tachycardia have Wolff-Parkinson-White syndrome.</span></span></span></p>",
      "correct_choice_id": 239528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60058,
      "choices": [
        {
          "id": 239533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bifascicular block conduction delay</span></span></span></p>"
        },
        {
          "id": 239534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left anterior fascicular block</span></span></span></p>"
        },
        {
          "id": 239535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left posterior fascicular block</span></span></span></p>"
        },
        {
          "id": 239536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right bundle branch block</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old woman with peripheral artery disease is evaluated prior to elective cholecystectomy. ECG is shown. Which of the following is the most likely electrocardiographic diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185806.png\" style=\"height:130px; width:400px\" /></span></span></p>",
      "unique_key": "Q7905464",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974450,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Left posterior fascicular block</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG demonstrates left posterior fascicular block, which occurs when conduction system disease involves the posterior fascicle of the left bundle branch. It is defined as a pathologic right axis (&gt;+90 degrees) with no other cause (such as right ventricular hypertrophy). The QRS duration is less than 120 ms with a negative QRS complex (small R wave and deep S wave) in leads I and aVL and a qR pattern in leads III and aVF. Left anterior fascicular block is recognized by a positive QRS complex in lead I and a negative QRS complex in lead aVF. Right bundle branch conduction disturbance combined with anterior or posterior left bundle branch block is called bifascicular block.</span></span></span></p>",
      "correct_choice_id": 239535,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60059,
      "choices": [
        {
          "id": 239537,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute posterior myocardial infarction</span></span></span></p>"
        },
        {
          "id": 239538,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brugada pattern</span></span></span></p>"
        },
        {
          "id": 239539,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Left ventricular hypertrophy</span></span></span></p>"
        },
        {
          "id": 239540,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right ventricular hypertrophy</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following conditions is demonstrated on this electrocardiogram?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-185926.png\" style=\"height:138px; width:400px\" /></span></span></p>",
      "unique_key": "Q8121136",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974451,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>D) Right ventricular hypertrophy</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This electrocardiogram demonstrates right ventricular hypertrophy. Electrocardiographic features characteristic of right ventricular hypertrophy include the following:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Evidence of right atrial enlargement</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right axis deviation or indeterminate axis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incomplete right bundle branch block (or an rSr&rsquo; in lead V1)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Low voltage</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Persistent precordial S waves</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Right ventricular strain pattern</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tall R wave in lead V1</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of several of these features supports a diagnosis of right ventricular hypertrophy. Features in this electrocardiogram include right axis deviation, persistent precordial S waves, a right ventricular strain pattern with downward concave ST-T&ndash;wave abnormality in V1&ndash;V3, and a tall R wave in lead V1.</span></span></span></p>",
      "correct_choice_id": 239540,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60060,
      "choices": [
        {
          "id": 239541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hypercalcemia</span></span></span></p>"
        },
        {
          "id": 239542,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hyperkalemia</span></span></span></p>"
        },
        {
          "id": 239543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Hypocalcemia</span></span></span></p>"
        },
        {
          "id": 239544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothermia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is the most likely cause of the findings on this electrocardiogram?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190037.png\" style=\"height:196px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q9521633",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974452,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Hypocalcemia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypocalcemia is the most likely cause of these electrocardiographic findings. Hypocalcemia typically causes prolongation of the QT interval due to an increase in the second phase of the ventricular action potential. QT prolongation may predispose the patient to ventricular arrhythmias and high-grade heart block.</span></span></span></p>",
      "correct_choice_id": 239543,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60061,
      "choices": [
        {
          "id": 239545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atenolol </span></span></span></p>"
        },
        {
          "id": 239546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Electrophysiology (EP) study </span></span></span></p>"
        },
        {
          "id": 239547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Flecainide </span></span></span></p>"
        },
        {
          "id": 239548,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Verapamil</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old woman experiences intermittent palpitations, shortness of breath, and light headedness. ECG is shown. Echocardiogram is normal. What is the most appropriate next step in management?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190157.png\" style=\"height:263px; width:400px\" /></span></span></p>",
      "unique_key": "Q5900107",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>B) Electrophysiology (EP) study</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ECG shows short PR interval and delta wave in multiple leads which is characteristic of Wolff-Parkinson-White (WPW) syndrome. An EP study is necessary to determine the risk of sudden cardiac death and to consider ablation of the accessory pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A. Atenolol and D. Verapamil (AV nodal blockers):</span></strong><span style=\"font-size:12.0pt\"> These medications are atrioventricular nodal blockers and may be unsafe if the patient has anterograde conduction down the accessory pathway during atrial fibrillation. These drugs promote rapid 1:1 conduction from the atria to the ventricles over the accessory pathway during atrial fibrillation, which can lead to very rapid ventricular rates and ventricular fibrillation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Flecainide:</span></strong><span style=\"font-size:12.0pt\"> It is an antiarrhythmic drug that is frequently used to treat paroxysmal atrial fibrillation and other arrhythmias. Flecainide is not indicated in this patient because the type and mechanism of the arrhythmia are unknown. This patient requires risk stratification, which can be accomplished with an electrophysiology study.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;In patients with suspected WPW syndrome, an EP study is indicated to assess arrhythmia risk and consider ablation of the accessory pathway.</span></span></span></p>",
      "correct_choice_id": 239546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60062,
      "choices": [
        {
          "id": 239549,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dobutamine echocardiography </span></span></span></p>"
        },
        {
          "id": 239550,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Echocardiography</span></span></span></p>"
        },
        {
          "id": 239551,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prophylactic pacemaker insertion </span></span></span></p>"
        },
        {
          "id": 239552,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">No further testing or intervention</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 81-year-old man with a history of hypertension and osteoarthritis is scheduled for elective hip arthroplasty. He is asymptomatic and has no history of cardiovascular disease. His ECG is shown. What is the most appropriate management?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-190419.png\" style=\"height:228px; width:400px\" /></span></span></p>",
      "unique_key": "Q1700728",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">D) No further testing or intervention</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient is having an asymptomatic Tri-fascicular block (RBBB + left posterior fascicular block + first-degree AV block) and it does not require further testing or intervention before elective surgery. The risk of progression to complete heart block is low (less than 2-3% per year).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dobutamine echocardiography:</span></strong><span style=\"font-size:12.0pt\"> Not indicated as there are no signs or symptoms of heart failure or ischemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Echocardiography:</span></strong><span style=\"font-size:12.0pt\"> Not necessary as the ECG findings are not suggestive of structural heart disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Prophylactic pacemaker insertion:</span></strong><span style=\"font-size:12.0pt\"> Not indicated in asymptomatic patients with bifascicular block and first-degree AV block.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Asymptomatic Tri-fascicular block does not require pacemaker implantation</span></span></span></p>",
      "correct_choice_id": 239552,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6814,
      "choices": [
        {
          "id": 27225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hospital admission </span></span></p>"
        },
        {
          "id": 27226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker implantation </span></span></p>"
        },
        {
          "id": 27227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Switch lisinopril to amlodipine </span></span></p>"
        },
        {
          "id": 27228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Reassurance and clinical monitoring</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 84-year-old man presents with fatigue and loss of energy. His ECG is shown. Upon vigorous exercise his heart rate reaches a maximum of 72/min. What is the most appropriate management?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091643.png\" style=\"height:139px; width:300px\" /></span></span></p>",
      "unique_key": "Q2417207",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974455,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Pacemaker implantation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has sinus nide dysfunction and he is symptomatic. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Symptomatic bradycardia, especially with an inadequate heart rate response to exercise, often requires pacemaker implantation to improve quality of life and prevent complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hospital admission:</span></strong><span style=\"font-size:12.0pt\"> Not necessary unless the patient is hemodynamically unstable. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Switching medications:</span></strong><span style=\"font-size:12.0pt\"> Unlikely to address the underlying bradycardia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Reassurance and monitoring:</span></strong><span style=\"font-size:12.0pt\"> Inadequate for symptomatic bradycardia with potential for adverse outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treat a patient with symptomatic bradycardia.</span></span></span></p>",
      "correct_choice_id": 27226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6815,
      "choices": [
        {
          "id": 27229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Left atrial appendage occlusion </span></span></p>"
        },
        {
          "id": 27230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker implantation </span></span></p>"
        },
        {
          "id": 27231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Rhythm control </span></span></p>"
        },
        {
          "id": 27232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">No additional therapy</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 70-year-old man with history of hypertension and stroke has been diagnosed with mildly symptomatic paroxysmal AF. He is currently taking rivaroxaban and metoprolol. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q9625805",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974456,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Rhythm control</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early rhythm control (antiarrhythmic drugs or ablation) has been shown to reduce cardiovascular death, stroke, and hospitalization for heart failure or acute coronary syndrome in patients with recent-onset AF and cardiovascular comorbidities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Left atrial appendage occlusion:</span></strong><span style=\"font-size:12.0pt\"> Indicated for stroke prevention in non-valvular AF but not the primary treatment for rhythm control. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pacemaker implantation: </span></strong><span style=\"font-size:12.0pt\">Not indicated for paroxysmal AF without symptomatic bradycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. No additional therapy:</span></strong><span style=\"font-size:12.0pt\"> Early rhythm control is recommended for this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with recently diagnosed atrial fibrillation and concomitant cardiovascular conditions, early rhythm control (antiarrhythmic drugs or ablation) reduces the primary composite end point of cardiovascular death, stroke, or hospitalization for heart failure or acute coronary syndrome compared with usual care.</span></span></span></p>",
      "correct_choice_id": 27231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6816,
      "choices": [
        {
          "id": 27233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Amiodarone </span></span></p>"
        },
        {
          "id": 27234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Catheter ablation </span></span></p>"
        },
        {
          "id": 27235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Flecainide </span></span></p>"
        },
        {
          "id": 27236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;Metoprolol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man with hypertension presents with acute shortness of breath, hypotension and palpitations. He has jugular venous distention and pulmonary crackles. ECG was done and is shown below. After successful cardioversion, what is the best treatment?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091936.png\" style=\"height:276px; width:500px\" /></span></span></p>",
      "unique_key": "Q4730483",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974457,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Catheter ablation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation and ECG findings are consistent with atrial flutter, a type of supraventricular tachycardia. Catheter ablation is the most appropriate additional treatment because it offers a high success rate (&gt;95%) and a low complication rate. It is considered the first-line therapy for typical atrial flutter.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amiodarone: &nbsp;</span></strong><span style=\"font-size:12.0pt\">Antiarrhythmic drug that can be used for atrial flutter, but catheter ablation is more definitive. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Flecainide: </span></strong><span style=\"font-size:12.0pt\">&nbsp;&nbsp;Another antiarrhythmic drug, but catheter ablation is preferred. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metoprolol: &nbsp;</span></strong><span style=\"font-size:12.0pt\">Beta-blocker, primarily used for rate control, not as effective for rhythm control in atrial flutter. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Catheter ablation is the definitive treatment for typical atrial flutter due to its high success rate and low complication rate.</span></span></span></p>",
      "correct_choice_id": 27234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6817,
      "choices": [
        {
          "id": 27237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Exercise ECG </span></span></p>"
        },
        {
          "id": 27238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Implantable loop recorder </span></span></p>"
        },
        {
          "id": 27239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Holter Monitoring </span></span></p>"
        },
        {
          "id": 27240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">30-day event monitor</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old woman presents with recurrent palpitations lasting 5-15 minutes, occue a few times per month and relieved by rest or deep breathing. The resting ECG is normal. What is the most appropriate diagnostic test?</span></span></p>",
      "unique_key": "Q9383591",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974458,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) 30-day event monitor</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-day event monitor is the most appropriate initial test for capturing infrequent and symptomatic arrhythmias (occurring less than daily but occurring over a month). The patient can activate the monitor when symptoms occur, provided that the symptoms last long enough to be captured by the device&#39;s active and retrospective capture. Symptoms that last longer than 1 to 2 minutes are ideally suited for event monitors</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Exercise ECG: </span></strong><span style=\"font-size:12.0pt\">Not indicated for evaluating palpitations occurring at rest. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Implantable loop recorder:</span></strong><span style=\"font-size:12.0pt\"> Reserved for very infrequent or unexplained syncope (which prevents the patient from triggering the devices). Records symptomatic and asymptomatic events (brady/tachy) over a very long period (months to years).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Holter monitoring</span></strong><span style=\"font-size:12.0pt\">: &nbsp;Usually records electrical activity continuously for 24-28 hours and most suited for patients with more frequent symptoms (e.g., daily). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-day event monitor is most appropriate for evaluating patients with palpitations who have symptoms that occur less than daily but frequently over the course of a month.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An implantable looping event recorder is most appropriate for infrequent or highly symptomatic arrhythmias in which the symptoms might preclude a patient from activating the device, such as syncope.</span></span></span></p>",
      "correct_choice_id": 27240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6818,
      "choices": [
        {
          "id": 27241,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Aspiration of the device pocket </span></span></p>"
        },
        {
          "id": 27242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker extraction </span></span></p>"
        },
        {
          "id": 27243,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Topical mupirocin </span></span></p>"
        },
        {
          "id": 27244,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Clinical observation and reassessment</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old man with a history of pacemaker insertion presents to you for routine review. You notice the pacemaker site like what is shown in the image. What is the most appropriate additional management?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092200.png\" style=\"height:223px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7721530",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974459,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Pacemaker extraction</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Image reveals erythema over the site of pacemaker, which is highly suggestive of a pocket infection. Cardiac device infection requires prompt removal of all hardware, debridement of the pocket, and antibiotic therapy (even if the patient is asymptomatic).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aspiration:</span></strong><span style=\"font-size:12.0pt\"> Not recommended for diagnostic purposes and can worsen infection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Topical mupirocin:</span></strong><span style=\"font-size:12.0pt\"> Ineffective for deep pocket infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option D. Observation:</strong> Inappropriate as the infection can worsen and lead to serious complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prompt device removal and antibiotic therapy is required in cases of suspected or confirmed cardiac device infection.</span></span></span></p>",
      "correct_choice_id": 27242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6819,
      "choices": [
        {
          "id": 27245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Brugada syndrome </span></span></p>"
        },
        {
          "id": 27246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Coronary artery disease </span></span></p>"
        },
        {
          "id": 27247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Long QT syndrome </span></span></p>"
        },
        {
          "id": 27248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Vasovagal syncope</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man presents with recurrent syncope without prodrome. His father died suddenly at age 45. ECG is shown. Physical examination and 2D Echo is normal. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092311.png\" style=\"height:194px; width:500px\" /></span></span></p>",
      "unique_key": "Q7168209",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974460,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Brugada syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of recurrent syncope, family history of sudden death, and the characteristic ECG findings of coved ST-segment elevation in V1-V3 strongly suggest Brugada syndrome, a genetic disorder that predisposes to ventricular arrhythmias and sudden cardiac death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Coronary artery disease: </span></strong><span style=\"font-size:12.0pt\">Unlikely in a young patient with no risk factors and normal ECG findings. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Long QT syndrome:</span></strong><span style=\"font-size:12.0pt\"> ECG would show a prolonged QT interval, not the Brugada pattern. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vasovagal syncope:</span></strong><span style=\"font-size:12.0pt\"> Typically has prodromal symptoms (lightheadedness, nausea) and normal ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiovascular syncopal events often occur suddenly and usually without a significant prodrome, although chest pain and palpitations may be present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of cardiovascular syncope include cardiac arrhythmia; coronary artery disease; and structural and obstructive disease, including aortic and pulmonary valve stenosis, obstructive hypertrophic cardiomyopathy, aortic dissection, and cardiac tamponade.</span></span></span></p>",
      "correct_choice_id": 27245,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6820,
      "choices": [
        {
          "id": 27249,
          "text": "<p><span style=\"font-size:11pt;\">Add aspirin</span></p>"
        },
        {
          "id": 27250,
          "text": "<p><span style=\"font-size:11pt;\">Increase metoprolol dose</span></p>"
        },
        {
          "id": 27251,
          "text": "<p><span style=\"font-size:11pt;\">Initiate oral anticoagulation</span></p>"
        },
        {
          "id": 27252,
          "text": "<p><span style=\"font-size:11pt;\">Reassurance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old woman presents with palpitations. Her ECG is shown. She is a known diabetic and hypertensive and currently taking metformin and metoprolol. What is the most appropriate management?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092619.png\" alt=\"\" width=\"500\" height=\"261\"></span></p>",
      "unique_key": "Q3593297",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974461,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Initiate oral anticoagulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient has an AF with controlled rate (78/min). Patients with nonvalvular AF and a CHA2DS2-VASc score  2 in men or  3 in women should be initiated on oral anticoagulation for stroke prevention (this patient has a CHA2DS2-VASc score of 4).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspirin: </strong>Insufficient for stroke prevention in high-risk patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increase metoprolol dosage:</strong> Not necessary as the ventricular rate is controlled.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Reassurance:</strong> Inappropriate as the patient is at high risk for stroke.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In stable patients with atrial fibrillation, the primary goals of therapy are to (1) prevent stroke, (2) control heart rate, (3) minimize or eliminate symptoms, and (4) modify underlying risk factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anticoagulation is indicated for stroke prevention in patients with nonvalvular atrial fibrillation who have a CHA2DS2-VASc score of 2 or greater in men or 3 or greater in women.</span></p>",
      "correct_choice_id": 27251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6821,
      "choices": [
        {
          "id": 27253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Cardiac MRI with stress perfusion</span></span></p>"
        },
        {
          "id": 27254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Electrophysiology (EP) study</span></span></p>"
        },
        {
          "id": 27255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Implantable cardioverter-defibrillator (ICD)</span></span></p>"
        },
        {
          "id": 27256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Implantable loop recorder (ILR)</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 42-year-old man presents with palpitations and lightheadedness. He was having significant work pressure over the last 2 weeks and he has not been sleeping well. ECG showed VT and he is successfully cardioverted in the ER. Echocardiogram is normal. What is the most appropriate initial management?</span></span></span></p>",
      "unique_key": "Q8720335",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974462,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Cardiac magnetic resonance imaging (MRI) with stress perfusion</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Idiopathic VT typically manifests as palpitations in the third to fifth decades of life, often triggered by stress, emotion, or sleeplessness. Sudden death is rare. </span><span style=\"font-size:12.0pt\">Before making a diagnosis of idiopathic VT, structural heart disease has to be ruled out. First test for structural heart disease would be echocardiogram and in patients with normal echo, cardiac MRI with stress perfusion is recommended to rule out subtle structural abnormalities (e.g., cardiomyopathies) that could be the cause of the arrhythmia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most idiopathic VT originate in the RV outflow tract, which gives rise to VT that has a LBBB morphology in V1 and an axis that is directed inferiorly, with tall R waves in II, III, and aVF. Idiopathic VT can also arise in the left ventricular outflow tract or in sleeves of myocardium that extend along the aortic root. Left ventricular origin is suspected when leads V1 or V2 have prominent R waves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. EP study:</span></strong><span style=\"font-size:12.0pt\"> May be indicated later if diagnosis of sustained VT is in doubt or if ablation is being considered (to localize the arrhythmogenic focus).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. ICD:</span></strong><span style=\"font-size:12.0pt\"> May be considered if there is VT + structural heart disease or HF with EF &le; 35%. In idiopathic VT, it is unnecessary. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. ILR:</span></strong> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It would be premature to consider ILR placement before assessment for structural heart disease. An ILR may be valuable to assess rare recurrences of arrhythmia and/or to assess symptoms, but further evaluation is needed first.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac MRI with stress perfusion is a valuable tool for evaluating the underlying cause of VT in patients with structurally normal hearts on echocardiography.</span></span></span></p>",
      "correct_choice_id": 27253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6823,
      "choices": [
        {
          "id": 27261,
          "text": "<p><span style=\"font-size:11pt;\">Administer 100% oxygen by NRBM</span></p>"
        },
        {
          "id": 27262,
          "text": "<p><span style=\"font-size:11pt;\">Administer procainamide IV</span></p>"
        },
        {
          "id": 27263,
          "text": "<p><span style=\"font-size:11pt;\">Administer 1 g calcium gluconate IV</span></p>"
        },
        {
          "id": 27264,
          "text": "<p><span style=\"font-size:11pt;\">Unsynchronized defibrillation with 200 J</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 81-year-old man is evaluated in the emergency department for chest pain. During the evaluation, he becomes unresponsive and pulseless. ECG is shown. what is the next best step in the management&nbsp;of&nbsp;this&nbsp;patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093042.png\" alt=\"\" width=\"400\" height=\"187\"></span></p>",
      "unique_key": "Q5620988",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974463,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Unsynchronized defibrillation with 200 J</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient is in ventricular fibrillation. Immediate defibrillation&nbsp; is required and treatment should proceed along advanced cardiac life support protocol. Defibrillation in this case should precede administration of oxygen. Medications will not be effective in the absence of circulation.</span></p>",
      "correct_choice_id": 27264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6824,
      "choices": [
        {
          "id": 27265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypocalcemia</span></span></p>"
        },
        {
          "id": 27266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypokalemia</span></span></p>"
        },
        {
          "id": 27267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypophosphatemia</span></span></p>"
        },
        {
          "id": 27268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypothermia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following disorders could account for the findings on the rhythm strip of a homeless man who was found unresponsive on the street?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093143.png\" style=\"height:70px; width:400px\" /></span></span></p>",
      "unique_key": "Q2066701",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974464,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Hypothermia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothermia most likely accounts for the findings&nbsp;shown&nbsp;on this electrocardiogram. In hypothermia, all of the electrocardiographic intervals are prolonged, including the PR interval, the QRS complex, the QT interval, and the R-R interval, owing to slowed impulse conduction through potassium channels. In addition, the J point is elevated, producing a characteristic J wave (Osborn wave) that represents distortion of the earliest phase of membrane repolarization. These changes are most prominent in the precordial leads V2&nbsp;through V5. This electrocardiogram demonstrates Osborn waves (arrows).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093206.png\" style=\"height:99px; width:500px\" /></p>",
      "correct_choice_id": 27268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6825,
      "choices": [
        {
          "id": 27269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Dual chamber Pacemaker</span></span></p>"
        },
        {
          "id": 27270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Single chamber pacemaker</span></span></p>"
        },
        {
          "id": 27271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">CRT device</span></span></p>"
        },
        {
          "id": 27272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Swan Ganz catheter</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following diagnoses is most consistent with the radiographic findings shown?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-112453.png\" style=\"height:195px; width:400px\" /></span></span></p>",
      "unique_key": "Q5689864",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974465,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Dual chamber Pacemaker</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The radiographic image shows leads in the right atrium (RA) and right ventricle (RV), consistent with a dual chamber pacemaker. This type of pacemaker is used to provide electrical stimulation to both the atrium and the ventricle, helping to coordinate the heart&#39;s rhythm. This patient in addition has features of pulmonary edema as well. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Single chamber pacemaker:</span></strong><span style=\"font-size:12.0pt\"> A single chamber pacemaker has only one lead, typically in the RV. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. CRT device:</span></strong><span style=\"font-size:12.0pt\"> A CRT device would include an additional lead positioned to pace the left ventricle via the coronary sinus, which is not seen in this image. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Swan Ganz catheter:</span></strong><span style=\"font-size:12.0pt\"> A Swan-Ganz catheter, used for measuring hemodynamic parameters, is not an implantable device and would appear as a different configuration on imaging.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dual chamber pacemaker has leads placed in both the right atrium and right ventricle. This device is used to maintain coordinated atrial and ventricular pacing in patients with specific types of heart block or other cardiac rhythm disturbances.</span></span></span></p>",
      "correct_choice_id": 27269,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6828,
      "choices": [
        {
          "id": 27281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Carotid sinus massage </span></span></p>"
        },
        {
          "id": 27282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Adenosine </span></span></p>"
        },
        {
          "id": 27283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Cardioversion </span></span></p>"
        },
        {
          "id": 27284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">IV metoprolol</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents with palpitations and giddiness for 2 hours. On arrival, BP is 80/60 mmHg. ECG is shown. What is the next step in management of this patient?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093714.png\" style=\"height:272px; width:500px\" /></span></span></p>",
      "unique_key": "Q4066841",
      "question_audio": null,
      "question_video": null,
      "map_id": 15974466,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Cardioversion</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is presenting with hemodynamic instability (low blood pressure) due to AVNRT (atrioventricular nodal re-entrant tachycardia). In this scenario, the immediate goal is to restore normal sinus rhythm and stabilize the patient. Synchronized cardioversion is the most appropriate initial treatment for hemodynamically unstable tachyarrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Carotid sinus massage:</span></strong><span style=\"font-size:12.0pt\"> This maneuver can sometimes terminate AVNRT, but it is not recommended in the setting of hemodynamic instability due to the risk of further complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Adenosine:</span></strong><span style=\"font-size:12.0pt\"> Adenosine is a first-line agent for stable AVNRT, but it is contraindicated in patients with asthma or bronchospasm and may not be effective in cases of hemodynamic instability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. IV metoprolol:</span></strong><span style=\"font-size:12.0pt\"> Beta-blockers like metoprolol are used for rate control in AVNRT, but they should not be the initial treatment in hemodynamically unstable patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&lsquo;</span></strong><span style=\"font-size:12.0pt\">If the patient is in shock, shock the patient !&rsquo;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture2.jpg\" style=\"height:708px; width:700px\" /></p>",
      "correct_choice_id": 27283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}